Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1260206.RAByDVRjYLzr-zuO0jFlrkucTt_cYDs1U53bUN39Cwngw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1260206.RAByDVRjYLzr-zuO0jFlrkucTt_cYDs1U53bUN39Cwngw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1260206.RAByDVRjYLzr-zuO0jFlrkucTt_cYDs1U53bUN39Cwngw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1260206.RAByDVRjYLzr-zuO0jFlrkucTt_cYDs1U53bUN39Cwngw130_provenance.
- NP1260206.RAByDVRjYLzr-zuO0jFlrkucTt_cYDs1U53bUN39Cwngw130_assertion description "[Our study suggests that PHA- 767491 could enhance the efficacy of 5-FU by inhibiting Chk1 phosphorylation and down-regulating Mcl1 expression through inhibition of Cdc7 and Cdk9, thus combinational administration of PHA-767491 with 5-FU could be potentially beneficial to patients with advanced and resistant HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260206.RAByDVRjYLzr-zuO0jFlrkucTt_cYDs1U53bUN39Cwngw130_provenance.
- NP1260206.RAByDVRjYLzr-zuO0jFlrkucTt_cYDs1U53bUN39Cwngw130_assertion evidence source_evidence_literature NP1260206.RAByDVRjYLzr-zuO0jFlrkucTt_cYDs1U53bUN39Cwngw130_provenance.
- NP1260206.RAByDVRjYLzr-zuO0jFlrkucTt_cYDs1U53bUN39Cwngw130_assertion SIO_000772 25643258 NP1260206.RAByDVRjYLzr-zuO0jFlrkucTt_cYDs1U53bUN39Cwngw130_provenance.
- NP1260206.RAByDVRjYLzr-zuO0jFlrkucTt_cYDs1U53bUN39Cwngw130_assertion wasDerivedFrom befree-2016 NP1260206.RAByDVRjYLzr-zuO0jFlrkucTt_cYDs1U53bUN39Cwngw130_provenance.
- NP1260206.RAByDVRjYLzr-zuO0jFlrkucTt_cYDs1U53bUN39Cwngw130_assertion wasGeneratedBy ECO_0000203 NP1260206.RAByDVRjYLzr-zuO0jFlrkucTt_cYDs1U53bUN39Cwngw130_provenance.
- befree-2016 importedOn "2016-02-19" NP1260206.RAByDVRjYLzr-zuO0jFlrkucTt_cYDs1U53bUN39Cwngw130_provenance.